advisorsecurities master

LNTHLantheus Holdings, Inc

CSNasdaq (XNAS)·USD

Identity

Security key
18115
Ticker
LNTH
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2015-06-25
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
LNTH

Detail

Enriched 2026-08-14 20:47

Market cap
$6,574,885,729.37
Shares outstanding (class)
65,272,369
Shares outstanding (weighted)
65,272,369
SIC
2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees
1,193
Location
NORTH BILLERICA, MA
Description

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data